Trial Profile
To evaluate bioequivalence and pharmacokinetic properties of two formulations of sofosbuvir and ledipasvir in healthy Egyptian volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Feb 2018
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 13 Feb 2018 New trial record
- 07 Feb 2018 Results published in the Clinical Drug Investigation